Product Images Symbravo
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Symbravo NDC 81968-020 by Axsome Therapeutics, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
3-ct Sample Bottle Label - bottle label 3 ct
This text describes a medication containing 20 mg of meloxicam and 10 mg of rizatriptan, with additional details on storage conditions and dosage recommendations. It provides instructions on storage temperature, usage, and not using the product if the seal is broken. The information includes the NDC code, a note that it is for oral use, and a mention that it is a patient sample not for sale. It also includes details on dispensing the Medication Guide to each patient, manufacturing information, and a copyright notice with an expiry date and lot number.*
9-ct Bottle Label - bottle label 9 ct
Manufacturer: Axsome Therapeutics, Inc. New York, NY 10007. This product is a tablet called SYMBRA%O’, containing 20mg of meloxicam and 10mg of rizatriptan. Each tablet also includes 14.5mg of rizatriptan benzoate. It is recommended to dispense the medication guide to each patient. The storage instructions advise keeping the tablets in the original bottle at 20°C to 25°C (68°F to 77°F), with excursions allowed to 15°C to 30°C (59°F to 86°F). It is important not to use the product if the seal is broken. For dosage information, refer to the Prescribing Information.*
Figure 1 - figure01
This text appears to be a graph showing the percentage of pain relief over time after taking different medications. The medications shown are Rizatriptan, Meloxicam, and Placebo. The x-axis represents time in hours from dose, while the y-axis represents the percentage of pain relief.*
Figure 2 - figure02
This text shows a graph representing the percentage of individuals achieving freedom from Migraine-Associated Symptoms for different medications at various time intervals after the dose. The medications compared are MBS Freedom, Rizatriptan, Meloxicam, and Placebo. The graph indicates the effectiveness of each medication in providing relief from migraine symptoms over time.*
Figure 3 - figure03
This text shows a pain relief chart comparing a medication called SYMBRAVO to a placebo over time in hours from dosage. The chart displays the percentage of pain relief achieved by each medication.*
Figure 4 - figure04
This data shows the percentage of individuals achieving MBS Freedom over time in hours from dose. The chart displays the percentages from 0% to 100% at varying time intervals. It appears to compare the effectiveness of two different treatments, one marked as "—e—SYMBRAVO" and the other as "Placebo".*
3-ct Sample Carton Label - sample carton
This text appears to be a description of a medication called Symbrayo, which is a tablet containing a combination of meloxicam and rizatriptan in the strengths of 20mg and 10mg respectively. Each bottle includes 3 tablets for oral use and is labeled as a patient sample, not for sale. It provides storage instructions, dosage information, and details on the manufacturer, Axsome Therapeutics, Inc. The medication guide should be dispensed along with the tablets.*
Structure - structure01
Structure - structure02
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
